FDA Approves Medication Related To Party-Drug 'Special K' In First Major Depression Treatment To Hit Market In Decades Kaiser Health NewsThe Food and Drug Administration approved Spravato as a fast-acting treatment for patients who have failed to find relief with at least two antidepressants.